215 related articles for article (PubMed ID: 26451311)
1. Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing.
Jang M; Yew PY; Hasegawa K; Ikeda Y; Fujiwara K; Fleming GF; Nakamura Y; Park JH
Oncoimmunology; 2015 Nov; 4(11):e1030561. PubMed ID: 26451311
[TBL] [Abstract][Full Text] [Related]
2. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.
Yoshida-Court K; Karpinets TV; Mitra A; Solley TN; Dorta-Estremera S; Sims TT; Delgado Medrano AY; El Alam MB; Ahmed-Kaddar M; Lynn EJ; Sastry KJ; Zhang J; Futreal A; Nick A; Lu K; Colbert LE; Klopp AH
PLoS One; 2023; 18(1):e0279590. PubMed ID: 36607962
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer.
Foord E; Arruda LCM; Gaballa A; Klynning C; Uhlin M
Sci Transl Med; 2021 Jan; 13(577):. PubMed ID: 33472952
[TBL] [Abstract][Full Text] [Related]
4. Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer.
Tsuji T; Eng KH; Matsuzaki J; Battaglia S; Szender JB; Miliotto A; Gnjatic S; Bshara W; Morrison CD; Lele S; Emerson RO; Wang J; Liu S; Robins H; Lugade AA; Odunsi K
Oncotarget; 2020 Jul; 11(27):2669-2683. PubMed ID: 32676168
[TBL] [Abstract][Full Text] [Related]
5. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
Ioannides CG; Platsoucas CD; Rashed S; Wharton JT; Edwards CL; Freedman RS
Cancer Res; 1991 Aug; 51(16):4257-65. PubMed ID: 1868446
[TBL] [Abstract][Full Text] [Related]
6. TCR repertoire intratumor heterogeneity of CD4
Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
[TBL] [Abstract][Full Text] [Related]
7. Clonality of CD4
Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
Front Immunol; 2019; 10():1336. PubMed ID: 31275310
[TBL] [Abstract][Full Text] [Related]
8. Relationship between T cell receptor clonotype and PD-1 expression of tumor-infiltrating lymphocytes in colorectal cancer.
Sukegawa K; Shitaoka K; Hamana H; Kobayashi E; Miyahara Y; Fujii K; Tsuda K; Saeki S; Nagata T; Ozawa T; Saito S; Fujii T; Muraguchi A; Shiku H; Kishi H
Eur J Immunol; 2020 Oct; 50(10):1580-1590. PubMed ID: 32441316
[TBL] [Abstract][Full Text] [Related]
9. Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient.
Ren Y; Li R; Feng H; Xie J; Gao L; Chu S; Li Y; Meng F; Ning Y
Front Immunol; 2022; 13():985187. PubMed ID: 36248860
[TBL] [Abstract][Full Text] [Related]
10. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous expansion of CD4+ tumor-infiltrating T-lymphocytes in clear cell renal cell carcinomas.
Zhang Q; Jia Q; Deng T; Song B; Li L
Biochem Biophys Res Commun; 2015 Feb; 458(1):70-6. PubMed ID: 25637538
[TBL] [Abstract][Full Text] [Related]
12. Aging-related changes in human T-cell repertoire over 20years delineated by deep sequencing of peripheral T-cell receptors.
Yoshida K; Cologne JB; Cordova K; Misumi M; Yamaoka M; Kyoizumi S; Hayashi T; Robins H; Kusunoki Y
Exp Gerontol; 2017 Oct; 96():29-37. PubMed ID: 28535950
[TBL] [Abstract][Full Text] [Related]
13. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
[TBL] [Abstract][Full Text] [Related]
14. A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4
Zhu W; Germain C; Liu Z; Sebastian Y; Devi P; Knockaert S; Brohawn P; Lehmann K; Damotte D; Validire P; Yao Y; Valge-Archer V; Hammond SA; Dieu-Nosjean MC; Higgs BW
Oncoimmunology; 2015 Dec; 4(12):e1051922. PubMed ID: 26587322
[TBL] [Abstract][Full Text] [Related]
15. Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.
Shitaoka K; Hamana H; Kishi H; Hayakawa Y; Kobayashi E; Sukegawa K; Piao X; Lyu F; Nagata T; Sugiyama D; Nishikawa H; Tanemura A; Katayama I; Murahashi M; Takamatsu Y; Tani K; Ozawa T; Muraguchi A
Cancer Immunol Res; 2018 Apr; 6(4):378-388. PubMed ID: 29475880
[TBL] [Abstract][Full Text] [Related]
16. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes.
Nakanishi K; Kukita Y; Segawa H; Inoue N; Ohue M; Kato K
Cancer Med; 2016 Sep; 5(9):2513-21. PubMed ID: 27465739
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
[TBL] [Abstract][Full Text] [Related]
19. Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme.
Lee M; Park C; Woo J; Kim J; Kho I; Nam DH; Park WY; Kim YS; Kong DS; Lee HW; Kim TJ
Front Immunol; 2019; 10():555. PubMed ID: 30967876
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.
Rudqvist NP; Pilones KA; Lhuillier C; Wennerberg E; Sidhom JW; Emerson RO; Robins HS; Schneck J; Formenti SC; Demaria S
Cancer Immunol Res; 2018 Feb; 6(2):139-150. PubMed ID: 29180535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
